RTFCCR and Anticancer Fund Launch Ingenious, a Joint Call to Support Innovative Treatment Strategies to Improve Cancer Survival 

May 8, 2026

The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and the Anticancer Fund (ACF) have launched Ingenious, a new joint Call for Research Projects (CfRP) aimed at supporting academic‑led clinical trials evaluating whether treatment strategies that incorporate predictive information can improve patient survival. 

Rather than focusing on the development of new drugs, this call seeks to optimize how existing, approved treatment options are used in clinical practice. In particular, the call encourages projects that: 

  • Integrate predictive information into treatment decision‑making, and 
  • Optimize current treatment strategies to improve outcomes while avoiding unnecessary treatment where possible. 

Eligibility Criteria 

Eligible proposals must: 

  • Explicitly integrate predictive information into the treatment strategy; 
  • Test clinical treatment strategies with improvement in survival outcomes as the primary objective; patient‑reported outcomes must be included; 
  • Use only interventions that are already approved or recommended in clinical guidelines for the cancer type studied. 

Funding Details 

  • Total budget: EUR 2,000,000 (EUR 1,000,000 RTFCCR / EUR 1,000,000 ACF) 
  • Institutional co‑funding: ≥20% required 
  • Funding request per project: No minimum or maximum amount 

Key Dates 

  • Letter of Intent deadline: 15 July 2026 
  • Full Application deadline: 5 October 2026 
  • Award notification: December 2026 

How to Apply 

This call follows a 2-step application process. Full details, Letter of Intent application form, and guidelines are available on the Anticancer Fund website: https://www.anticancerfund.org/en/RFA  

We strongly encourage you to consult the guidelines for applicants before applying.  

For any questions or to discuss eligibility, feel free to contact us at apply@anticancerfund.org

About the Rising Tide Foundation for Clinical Cancer Research 

Founded in 2010 and headquartered in Schaffhausen, Switzerland, the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) is a charitable, non‑profit organization dedicated to advancing patient‑centered clinical cancer research. Its mission is to support innovative clinical trials that lead to less toxic therapies, earlier detection, and improved quality of life for cancer patients, with a strong focus on projects that address real patient needs and deliver meaningful impact on survival and well‑being. 

Learn more at: https://www.risingtide-foundation.org 

About Anticancer Fund 

Anticancer Fund is a Belgian research foundation with a global vision. We help where it matters most: we drive research that would otherwise be left undone, provide reliable information about cancer and treatments and help shape policy that makes a difference for patients. For us, a cancer diagnosis isn’t just a medical term: it’s a story, a life, and a family. 

For more information, visit www.anticancerfund.org 

Scroll to Top